Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-β isoforms

Journal of Cellular Physiology

Volumn 202, Issue 1, 2005, Pages 304-313

  Makhijani, Nalini S ^a   Bischoff, David S ^a   Yamaguchi, Dean T ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPSIN; AGGRECAN; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; MESSENGER RNA; OXIDOREDUCTASE; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ARTICLE; BONE REMODELING; CARTILAGE CELL; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; MARKER GENE; MESENCHYME CELL; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; BONE DEVELOPMENT; BONE REGENERATION; CELL COUNT; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CHEMOTAXIS; CHONDROCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; OSTEOBLASTS; OXIDOREDUCTASES; PROTEIN ISOFORMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TRETINOIN;

ANIMALIA;

EID: 9944253559     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20128     Document Type: Article

References (60)

1. Abdelouahed M, Ludlow A, Brunner G, Lawler J. 2000. Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1. J Biol Chem 275:17933-17939.
2. Aherns M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G. 1993. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12:871-880.
3. Beck LS, Ammann AJ, Aufdemorte TB, Deguzman L, Xu Y, Lee WP, McFatridge LA, Chen TL. 1991. In vivo induction of bone by recombinant human transforming growth factor beta 1. J Bone Miner Res 6:961-968.
4. Beck LS, Armento EP, Xu Y, Deguzman L, Lee WP, Nguyen T, Gillett NA. 1993. TGF-beta 1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-beta1. J Bone Miner Res 8:753-761.
5. Bolander ME. 1992. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200:165-170.
6. Bonewald LF, Dallas SL. 1994. Role of active and latent transforming growth factor β in bone formation. J Cell Biochem 55:350-357.
7. Breen EC, Ignotz RA, McCabe L, Stein JL, Stein GS, Lian JB. 1994. TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol 160:323-335.
8. Cassiede P, Dennis JE, Ma F, Caplan AL. 1996. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner Res 11:1264-1273.
9. Chandrasekhar S, Harvey AK. 1996. Modulation of PDGF mediated osteoblast chemotaxis by leukemia inhibitor factor (LIF). J Cell Physiol 169:481-490.
10. Cho TJ, Gerstenfeld LC, Einhorn TA. 2002. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17:513-520.
11. Chung CY, lida-Klein A, Wyatt LE, Rudkin GH, Ishida K, Yamaguchi DT, Miller TA. 1999. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2. Biochem Biophys Res Commun 265:246-251.
12. Eyre-Brook AL. 1984. The periosteum: Its function reassessed. Clin Orthop 189:300-307.
13. Fava RA, Casey TT, Wilcox J, Pelton RW, Moses HL, Nanney LB. 1990. Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules. Blood 76:1946-1955.
14. Fiedler J, Roderer G, Gunther KP, Brenner RE. 2002. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 87:305-312.
15. Gazit D, Ebner R, Kahn AJ, Derynck R. 1993. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol 7:189-198.
16. Gibson DF, Hossain MZ, Goldberg GS, Acevedo P, Bertram JS. 1994. The mitogenic effects of transforming growth factors beta 1 and beta 2 in C3H/10T1/2 cells occur in the presence of enhanced gap junctional communication. Cell Growth Differ 5:687-696.
17. Gordon EM, Skotzko M, Kundu RK, Han B, Andrades J, Nimni M, Anderson WF, Hall FL. 1997. Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta-1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. Hum Gene Ther 8:1385-1394.
18. Gosh-Choudhury N, Windle JJ, Koop BA, Harris MA, Guerrero DL, Wozney JM, Mundy GR, Harris SE. 1996. Immortalized murine osteoblasts derived from BMP-2 T-antigen expressing transgenic mice. Endocrinology 137:331-339.
19. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. 1995. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1:932-937.
20. Grundnes O, Reikeras O. 1993a. The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 64:340-342.
21. Grundnes O, Reikeras O. 1993b. The role of hematoma and periosteal sealing for fracture healing in rats. Acta Orthop Scand 64:47-49.
22. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR. 1994. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-863.
23. Harrison P, Cramer EM. 1993. Platelet alpha-granules. Blood Rev 7:52-62.
24. Hughes FJ, Aubin JE, Heersche JN. 1992. Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor beta. Bone Miner 19:63-74.
25. Kassem M, Kveiborg M, Eriksen EF. 2000. Production and action of transforming growth factor-beta in human osteoblast cultures: Dependence on cell differentiation and modulation by calcitriol. Eur J Clin Invest 30:429-437.
26. Katagiri T, Lee T, Takeshima H, Suda T, Tanaka H, Omura S. 1990. Transforming growth factor-beta modulates proliferation and differentiation of mouse clonal osteoblastic MC3T3-E1 cells depending on their maturation stages. Bone Miner 11:285-293.
27. Kohama K, Nonaka K, Hosokawa R, Shum L, Ohishi M. 2002. TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. J Dent Res 81:688-694.
28. Lind M, Deleuran B, Thestrup-Pedersen K, Soballe K, Eriksen EF, Bunger C. 1995a. Chemotaxis of human osteoblasts. Effects of osteotropic growth factors. APMIS 103:140-146.
29. Lind M, Deleuran B, Yssel H, Fink-Eriksen E, Thestrup-Pedersen K. 1995b. IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts. Cytokine 7:78-82.
30. Liu X, Kohyama T, Kobayashi T, Abe S, Kim HJ, Reed EC, Rennard SI. 2003. Cigarette smoke extract inhibits chemotaxis and collagen gel contraction mediated by human bone marrow osteoprogenitor cells and osteoblast-like cells. Osteoporos Int 14:235-242.
31. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
32. Lucas PA. 1989. Chemotactic response of osteoblast-like cells to transforming growth factor beta. Bone 10:459-463.
33. Lucas PA, Caplan AI. 1988. Chemotactic response of embryonic limb bud mesenchymal cells and muscle-derived fibroblasts to transforming growth factor-β. Connect Tissue Res 18:1-7.
34. Mackie EJ, Trechsel U. 1990. Stimulation of bone formation in vivo by transforming growth factor-beta: Remodeling of woven bone and lack of inhibition by indomethacin. Bone 11:295-300.
35. Marcelli C, Yates AJ, Mundy GR. 1990. In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. J Bone Miner Res 5:1087-1096.
36. Millan FA, Denhez F, Kondaiah P, Akhurst RJ. 1991. Embryonic gene expression patterns of TGF beta 1, beta 2, and beta 3 suggest different developmental functions in vivo. Development 111:131-143.
37. Mizuno K, Mineo K, Tachibana T, Sumi M, Matsubara T, Hirohata K. 1990. The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma. J Bone Joint Surg Br 72:822-829.
38. Murata H, Zhou L, Ochoa S, Hasan A, Badiavas E, Falanga V. 1997. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta 1-dependent and independent mechanisms. J Invest Dermatol 108:258-262.
39. Noda M, Camilliere JJ. 1989. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 134:2991-2994.
40. Noda M, Rodan GA. 1987. Type beta transforming growth factor (TGF beta) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J Cell Physiol 133:426-437.
41. O'Driscoll SW, Fitzsimmons JS. 2001. The role of periosteum in cartilage repair. Contemp Orthop 391S:S190-S207.
42. Olutoye OO, Yager DR, Cohen IK, Diegelmann RF. 1996. Lower cytokine release by fetal porcine platelets: A possible explanation for reduced inflammation after fetal wounding. J Pediatr Surg 31:91-95.
43. Opperman LA, Nolen AA, Ogle RC. 1997. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res 12:301-310.
44. Panagakos FS. 1993. Insulin-like growth factors-I and -II stimulate chemotaxis of osteoblasts isolated from fetal rat calvaria. Biochimie 75:991-994.
45. Peterson WJ, Tachiki KH, Yamaguchi DT. 2002. Extracellular matrix alters the relationship between tritiated thymidine incorporation and proliferation of MC3T3-E1 cells during osteogenesis in vitro. Cell Prolif 35:9-22.
46. Pfeilschifter J, Wolf O, Naumann A, Minne HW, Mundy GR, Ziegler R. 1990. Chemotactic response of osteoblast like cells to transforming growth factor beta. J Bone Miner Res 5:825-830.
47. Raghow R. 1994. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 8:823-831.
48. Rosen D, Miller SC, DeLeon E, Thompson AY, Bentz H, Mathews M, Adams S. 1994. Systematic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15:355-359.
49. Rudkin GH, Yamaguchi DT, Ishida K, Peterson WJ, Bahadosingh F, Thye D, Miller TA. 1996. Transforming growth factor-beta, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells. J Cell Physiol 168:433-441.
50. Slater M, Patava J, Kingham K, Mason RS. 1995. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 13:655-663.
51. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. 1987. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039-1045.
52. Talley-Ronsholdt DJ, Lajiness E, Nagodawithana K. 1995. Transforming growth factor beta inhibition of mineralization by neonatal rat osteoblasts in monolayer and collagen gel culture. In Vitro Cell Dev Biol Anim 31:274-282.
53. Taylor SM, Jones PA. 1979. Multiple new phenotypes induced in 10T1/ 2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779.
54. Tsunoda M, Mizuno K, Matsubara T. 1993. The osteogenic potential of fracture hematoma and its mechanism on bone formation - Through fracture hematoma culture and transplantation of freeze-dried hematoma. Kobe J Med Sci 39:35-50.
55. Wang EA, Israel DI, Kelly S, Luxenberg DP. 1993. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/ 2 and 3T3 cells. Growth Factors 9:57-71.
56. Weibrich G, Kleis WK, Hafner G, Hitzler WE. 2002. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30:97-102.
57. Yamaguchi A. 1995. Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily. Semin Cell Biol 6:165-173.
58. Yoo JU, Johnstone B. 1998. The role of osteochondral progenitor cells in fracture repair. Clin Orthop 355S:S73-S81.
59. Zhou H, Hammonds RG, Jr. Findlay DM, Martin TJ, Ng KW. 1993. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts. J Cell Physiol 155:112-119.
60. Zhou H, Choong PC, Chou ST, Kartsogiannis V, Martin TJ, Ng KW. 1995. Transforming growth factor beta 1 stimulates bone formation and resorption in an in-vivo model in rabbits. Bone 17:443S-448S.